Analyses / Impact Analysis / 119 · HR 6238 Impact Analysis

119-HR-6238 Investigative Journalist Impact Analysis

119 · HR 6238 NIH IMPROVE Act

Bottom-line assessment
Bottom line. Analytical stance: neutral. The bill’s authorized funding is modest but targeted at a large, preventable burden with stark inequities. Because H.R. 6238 principally codifies and funds research rather than implementing care delivery, realized benefits hinge on project selection, equity‑minded award distribution, rigorous evaluation, and strong coordination with CDC/HRSA programs to translate results into practice. [1]GPO govinfo — H.R. 6238 (IH) – NIH IMPROVE Act (official bill text)
Authorized funding per year (FY2026–FY2031)
73.4M
U.S. maternal mortality rate (2023)
18.6/100k
Black maternal mortality rate (2023)
50.3/100k
Severe maternal morbidity rate (2021)
101.1/10k
Published
29 May 2026
Updated
29 May 2026
Tags
impact-analysis · health · maternal-health
Unvetted
01 · Section

Summary

What the bill does. H.R. 6238 establishes in statute the NIH-wide IMPROVE Initiative on maternal health, authorizing $73.4M per year for FY2026–FY2031 and permitting NIH to use grants, contracts, and cooperative agreements. This largely codifies an ongoing NIH effort rather than creating a wholly new program. [1]GPO govinfo — H.R. 6238 (IH) – NIH IMPROVE Act (official bill text)

Why it matters. U.S. maternal outcomes remain a concern: the national maternal mortality rate fell to 18.6 deaths per 100,000 live births in 2023 yet remains highly unequal (50.3 for non‑Hispanic Black women vs. 14.5 for White women), and severe maternal morbidity (SMM) during delivery rose 40% from 2016 to 2021 (72.0 → 101.1 per 10,000). Many pregnancy‑related deaths are preventable. [2]CDC/NCHS — Maternal Mortality Rates in the United States, 2023 (NCHS Data Brief…

Authorized funding per year (FY2026–FY2031)
73.4M
U.S. maternal mortality rate (2023)
18.6/100k
Black maternal mortality rate (2023)
50.3/100k
Severe maternal morbidity rate (2021)
101.1/10k
Preventable pregnancy‑related deaths (2017–2019)
84%

Process note. On May 21, 2026, the House Energy & Commerce Committee approved H.R. 6238 by 46–0 during full committee markup (final passage at markup), indicating bipartisan support as it advanced from committee. [3]U.S. House Committee Repository — House Energy & Commerce – Roll Call Vote #11…

02 · Section

Economic Effects

Direct federal outlays are modest relative to NIH’s overall budget; downstream cost effects hinge on whether funded research yields scalable, effective interventions.

  • Scale and flow of funds. The bill authorizes $73.4M annually through FY2031, a small fraction of NIH’s roughly $46–48B annual program level; funds would primarily flow via extramural awards to universities, medical centers, and community partners. [1]GPO govinfo — H.R. 6238 (IH) – NIH IMPROVE Act (official bill text)
  • Local economic activity. Research grants typically support personnel and services in recipient regions; however, benefits may cluster where research capacity is already concentrated, underscoring equity considerations for award distribution. [4]NIH RePORT — NIH RePORT: Awards by Location and Organization
  • Potential cost offsets. SMM events are associated with substantially higher delivery‑admission costs (about 2.5× vs. uncomplicated deliveries in one U.S. center) and higher spending in commercial and Medicaid populations; research that reduces SMM could yield medical cost savings over time. [5]American Journal of Perinatology (via PMC) — Directly Measured Costs of Severe…
  • Evidence‑to‑policy pathway. By design, most near‑term effects are knowledge generation (trials, cohort studies, implementation research). Any broad payer or provider savings would materialize only if findings are translated into practice and reimbursed. (No CBO estimate was posted for this bill as of May 29, 2026.) [6]Library of Congress — Congress.gov – H.R. 6238 bill page (showing no CBO estima…
03 · Section

Social Effects

The program’s objectives emphasize reducing preventable mortality, severe morbidity, and disparities—areas where current evidence indicates large, inequitable burdens.

  • Disparities focus. The 2023 maternal mortality rate for non‑Hispanic Black women (50.3 per 100,000) remained over 3× that of White women (14.5); centering research on disproportionately affected populations addresses documented inequities. [2]CDC/NCHS — Maternal Mortality Rates in the United States, 2023 (NCHS Data Brief…
  • Preventability window. Review committee evidence indicates approximately 84% of pregnancy‑related deaths from 2017–2019 were preventable, supporting investments in identification of modifiable risks and implementation strategies, including the extended postpartum period. [7]CDC — Pregnancy-Related Deaths: Data From MMRCs in 36 States, 2017–2019 (PDF)
  • Rural access risks. Rural closures and low‑volume obstetric settings are linked to access and safety concerns; research that tests regionalized care and referral models could inform targeted solutions. [8]U.S. GAO — GAO-23-105515: Availability of Hospital‑Based Obstetric Care in Rura…
  • Community‑based supports. Trials and reviews suggest continuous labor support (e.g., trained doulas) improves several delivery outcomes; rigorous evaluation of such community‑based models within IMPROVE could clarify impact by payer and setting. [9]Cochrane — Cochrane Review: Continuous support for women during childbirth
  • Data quality and measurement. Persistent issues in vital statistics (e.g., pregnancy‑checkbox misclassification) complicate trend analysis; projects that improve data capture and linkage can sharpen targeting and evaluation. [10]CDC/NCHS — NCHS Vital & Health Statistics, Series 3 No. 44: Impact of the Pregn…
04 · Section

Environmental Effects

Direct environmental effects of the bill are minimal; indirect effects could be material if research informs exposure‑reduction policies or heat‑health adaptations that benefit pregnant and postpartum people.

  • Air pollution. Meta‑analyses link higher gestational PM2.5 exposure with elevated preterm birth risk; studies also associate ambient pollution with adverse neonatal outcomes—areas ripe for etiologic and implementation research under IMPROVE. [11]PubMed — Gestational exposure to ambient particulate matter and preterm birth:…
  • Heat exposure. Large U.S. cohort analyses associate prenatal heat (including short‑ and long‑term exposure) with higher severe maternal morbidity risk, suggesting potential gains from surveillance, counseling, and adaptive interventions. [12]JAMA Network Open — Analysis of Heat Exposure During Pregnancy and Severe Mater…
  • Policy relevance. Findings on environmental drivers (heat, PM2.5) could inform cross‑sector policies (public health, housing, climate adaptation) that indirectly reduce maternal complications and downstream emissions‑related burdens. [12]JAMA Network Open — Analysis of Heat Exposure During Pregnancy and Severe Mater…
05 · Section

Temporal Analysis

Impacts unfold over distinct horizons.

  1. 0–2 years (setup and continuity). Funding sustains and potentially scales an existing NIH‑wide initiative; awards, networks, and data infrastructure (e.g., cohorts, registries) dominate early outputs. [13]NICHD/NIH — About the NIH IMPROVE Initiative
  2. 2–5 years (evidence generation). Expect peer‑reviewed findings from trials and observational studies on leading causes of mortality/SMM, postpartum risks, and disparities, including evaluations of community‑based interventions. [1]GPO govinfo — H.R. 6238 (IH) – NIH IMPROVE Act (official bill text)
  3. 5+ years (translation and uptake). System‑level effects—reduced SMM, narrower disparities, cost offsets—depend on clinical and payer adoption, quality‑improvement collaboratives, and state/federal policy changes based on the research. Trends in SMM underscore the need for effective translation. [14]AHRQ/HCUP — HCUP Statistical Brief #312: Trends in Severe Maternal Morbidity, 2…
06 · Section

Unintended Consequences and Implementation Risks

07 · Section

Assessment

Bottom line. Analytical stance: neutral. The bill’s authorized funding is modest but targeted at a large, preventable burden with stark inequities. Because H.R. 6238 principally codifies and funds research rather than implementing care delivery, realized benefits hinge on project selection, equity‑minded award distribution, rigorous evaluation, and strong coordination with CDC/HRSA programs to translate results into practice. [1]GPO govinfo — H.R. 6238 (IH) – NIH IMPROVE Act (official bill text)

08 · Section

Sourcing (selected)

Key federal and peer‑reviewed sources underlying this analysis.

  • Bill text and status: govinfo GPO (bill text) and House committee vote PDF (markup). [1]GPO govinfo — H.R. 6238 (IH) – NIH IMPROVE Act (official bill text)
  • NIH program context: NICHD IMPROVE overview; NIH news on Maternal Health Research Centers of Excellence. [13]NICHD/NIH — About the NIH IMPROVE Initiative
  • Outcomes and disparities: CDC NCHS maternal mortality (2023); preventability (MMRCs). [2]CDC/NCHS — Maternal Mortality Rates in the United States, 2023 (NCHS Data Brief…
  • SMM trends and costs: AHRQ HCUP Statistical Brief #312; cost differentials with SMM. [14]AHRQ/HCUP — HCUP Statistical Brief #312: Trends in Severe Maternal Morbidity, 2…
  • Environmental links: JAMA Network Open (heat–SMM); meta‑analysis on PM2.5 and preterm birth. [12]JAMA Network Open — Analysis of Heat Exposure During Pregnancy and Severe Mater…
  • Governance/coordination: GAO reports on maternal health performance measurement and coordination. [15]U.S. GAO — GAO-24-106271: HHS Should Improve Assessment of Efforts to Address W…
Sources cited
  1. [1] H.R. 6238 (IH) – NIH IMPROVE Act (official bill text) GPO govinfo
  2. [2] Maternal Mortality Rates in the United States, 2023 (NCHS Data Brief 521) CDC/NCHS
  3. [3] House Energy & Commerce – Roll Call Vote #11 on H.R. 6238 (Final passage at markup) U.S. House Committee Repository
  4. [4] NIH RePORT: Awards by Location and Organization NIH RePORT
  5. [5] Directly Measured Costs of Severe Maternal Morbidity Events During Delivery Admission American Journal of Perinatology (via PMC)
  6. [6] Congress.gov – H.R. 6238 bill page (showing no CBO estimate at time of access) Library of Congress
  7. [7] Pregnancy-Related Deaths: Data From MMRCs in 36 States, 2017–2019 (PDF) CDC
  8. [8] GAO-23-105515: Availability of Hospital‑Based Obstetric Care in Rural Areas U.S. GAO
  9. [9] Cochrane Review: Continuous support for women during childbirth Cochrane
  10. [10] NCHS Vital & Health Statistics, Series 3 No. 44: Impact of the Pregnancy Checkbox and Misclassification CDC/NCHS
  11. [11] Gestational exposure to ambient particulate matter and preterm birth: Updated meta‑analysis PubMed
  12. [12] Analysis of Heat Exposure During Pregnancy and Severe Maternal Morbidity JAMA Network Open
  13. [13] About the NIH IMPROVE Initiative NICHD/NIH
  14. [14] HCUP Statistical Brief #312: Trends in Severe Maternal Morbidity, 2016–2021 (PDF) AHRQ/HCUP
  15. [15] GAO-24-106271: HHS Should Improve Assessment of Efforts to Address Worsening Maternal Outcomes U.S. GAO
  16. [16] gao.gov

Discussion